Skip to main content

UBRS20152 / BTCRC BRE15-024 / O'Regan

Research Question:
Do the drugs Ribociclib and Bicalutamide help treat breast cancer?

Basic Study Information

This is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.

Location: University of Rochester Medical Center
Study Reference #: STUDY00006374

Lead Researcher (Principal Investigator)

Lead Researcher:  Ruth O'Regan

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search